Skip to main content
Sugentech, Inc. logo

Sugentech, Inc. — Investor Relations & Filings

Ticker · 253840 ISIN · KR7253840003 KO Manufacturing
Open in API
Filings indexed 296 across all filing types
Latest filing 2022-12-14 Regulatory Filings
Country KR South Korea
Listing KO 253840

About Sugentech, Inc.

https://www.sugentech.com/en/

Sugentech, Inc. is an in-vitro diagnostics (IVD) company that develops and commercializes diagnostic solutions by integrating biotechnology, nanotechnology, and information technology. The company's product portfolio serves diverse healthcare settings, from large hospitals and laboratories to smaller clinics and home users. Key offerings include automated multi-immunoblot systems, point-of-care testing (POCT) platforms, and self-diagnostic kits for personal use, such as ovulation and pregnancy tests. Sugentech leverages proprietary technologies in developing high-level antibodies and advanced nanoparticles to create highly sensitive and precise immunochemical assays, underpinning its digital healthcare diagnostic platform for personalized medicine.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal notice of the procedural steps required for the meeting. Given its nature as a regulatory notification of a corporate event, it fits best under the RNS category.
2022-12-14 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Sugentech Inc., covering the period from 2022.01.01 to 2022.09.30. It contains detailed company information, business descriptions, financial data, and management disclosures, which are characteristic of a comprehensive interim financial report. It is not a mere announcement or certification, as it contains substantive financial and operational information. 9M 2022
2022-11-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (DART). This is a standard regulatory filing used to disclose insider transactions or changes in share ownership by company directors and executives. Based on the provided categories, this fits the 'Director's Dealing' (DIRS) classification, which covers reports of personal share transactions by company directors and executives.
2022-10-18 Korean
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for Sugentech Inc. for the period ending June 30, 2022. It contains detailed company information, business descriptions, financial data, and management discussions, which are characteristic of an interim financial report. It is not a mere announcement or certification, but the full report itself. H1 2022
2022-08-12 Korean
기타경영사항(자율공시)(전환우선주의 보통주 전환청구)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) regarding the conversion of convertible preferred shares into common shares. This type of corporate action directly impacts the company's capital structure and share count. According to the provided definitions, 'Share Issue/Capital Change' (SHA) is the most appropriate category for announcements regarding new share issues or capital changes resulting from conversions.
2022-07-29 Korean
기타경영사항(자율공시)(전환우선주의 보통주 전환청구)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Sugentech regarding the conversion of convertible preferred shares into common shares. This involves a change in the company's capital structure and share count. According to the filing definitions, 'Share Issue/Capital Change' (SHA) covers announcements regarding new share issues or other capital changes, which directly applies to the conversion of preferred shares into common stock.
2022-07-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.